title: Circadian rhythms in toxic effects of the serotonin antagonist ondansetron in mice.
abstract: The aim of the study was to learn whether the lethal and the motor incoordination (ataxia) side effect of ondansetron (Zophren) administration is dosing-time dependent. Ondansetron is a serotonin 5-HT3 receptor antagonist used primarily to control nausea and vomiting arising from cytotoxic chemo- and radiotherapy. A total of 210 male Swiss mice 10 to 12 weeks of age were synchronized for 3 weeks by 12 h light (rest span)/12 h dark (activity span). Different doses of ondansetron were injected intraperitoneally (i.p.) at fixed times during the day to determine both the sublethal (TD50) and lethal (LD50) doses, which were, respectively, 3.7 +/- 0.6 mg/kg and 4.6 +/- 0.5 mg/kg. In the chronotoxicologic study a single dose of ondansetron (3.5 mg/kg, i.p.) was administered to different and comparable groups of animals at four different circadian stages [1, 7, 13, and 19 h after light onset (HALO)]. The lethal toxicity was statistically significantly dosing time-dependent (chi2 = 21.51, p < 0.0001). Drug dosing at 1 HALO resulted in 100% survival rate whereas drug dosing at 19 HALO was only one-half that (52%). Similarly, lowest and highest ataxia occurred when ondansetron was injected at 1 and 19 HALO, respectively (chi2 = 22.24, p < 0.0001). Effects on rectal temperature were also dosing-time related (Cosinor analysis, p < 0.0001). The characteristics of the waveform describing the temporal patterns differed between the studied variables, e.g., lethal toxicity and survival rate showing two peaks and rectal temperature showing one peak in the 24 h time series waveform pattern. Cosinor analysis also revealed a statistically significant ultradian (tau = 8 h) rhythmic component in the considered variables. Differences in curve patterns in toxicity elicited by ondansetron on a per end point basis are hypothesized to represent the phase relations between the identified 24 h and 8 h periodicities.
authors.affiliation: Laboratoire d'Immuno-Oncologie Moléculaire, Faculté de Médecine, Monastir, Tunisia.
authors.forename: Achraf
authors.initials: A
authors.lastname: Khedhaier
authors.forename: Mossadok
authors.initials: M
authors.lastname: Ben Attia
authors.forename: Wafa
authors.initials: W
authors.lastname: Gadacha
authors.forename: Mamane
authors.initials: M
authors.lastname: Sani
authors.forename: Kamel
authors.initials: K
authors.lastname: Bouzouita
authors.forename: Lotfi
authors.initials: L
authors.lastname: Chouchane
authors.forename: Mohamed
authors.initials: M
authors.lastname: Mechkouri
authors.forename: Alain
authors.initials: A
authors.lastname: Reinberg
authors.forename: Naceur A
authors.initials: NA
authors.lastname: Boughattas
mesh_terms: D000818:Animals; D001259:Ataxia / Q000139:chemically induced; D001831:Body Temperature; D001835:Body Weight; D002940:Circadian Rhythm / Q000502:physiology*; D006801:Humans; D008297:Male; D051379:Mice; D017294:Ondansetron / Q000633:toxicity*; D011897:Random Allocation; D012702:Serotonin Antagonists / Q000633:toxicity*; D015996:Survival Rate
chemical_list: D012702:Serotonin Antagonists; D017294:Ondansetron